-
Ferring and IMAB sign licensing agreement granting IMAB exclusive rights in Asia to olamkicept for the treatment of autoimmune disease
-Ferring Pharmaceuticals and IMAB today announced that they have signed a licensing agreement which grants IMAB exclusive rights…
0 -
Ferring receives EU approval for REKOVELLE® (follitropin delta)
-Ferring Pharmaceuticals announced today that the European Commission (EC) has granted marketing authorisation for REKOVELLE®…
-
Launch of NOCDURNA® (desmopressin)
-Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Ferring Pharmaceuticals collaborates with MetaboGen AB on development of microbiome-based treatment for intrahepatic cholestasis of pregnancy (ICP)
-Ferring Pharmaceuticals and MetaboGen AB today announced a multi-year research collaboration…
Archive for December, 2016
2016 > December